ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G. Kemps, Brianna Empringham, Laura S. Hiemcke‐Jiwa et al.|Blood|2021Cited by 157
High <i>Skp2</i> Expression Characterizes High-Risk Neuroblastomas Independent of <i>MYCN</i> StatusFrank Westermann, Manfred Schwab, Kai-Oliver Henrich et al.|Clinical Cancer Research|2007Cited by 49